Liver Disease Diagnostics Market Poised to Hit $22.74 Bn by 2031 with a Remarkable 7.0% CAGR | Abbott, Roche and Thermo Fisher Scientific

Los Angeles, United States - QY Research has unveiled its latest study titled "Global Liver Disease Diagnostics Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031." This newly released report delivers a comprehensive overview of the global Liver Disease Diagnostics market, analyzing the forces shaping its growth trajectory and providing valuable insights for stakeholders, investors, and industry professionals. the research covers key areas including market dynamics, segmentation, regional performance, competitive landscape, and emerging technology trends that are redefining industry standards. Backed by reliable data and expert analysis, the report serves as a trusted guide to understanding both microeconomic and macroeconomic factors driving market evolution.

The global market for Liver Disease Diagnostics was estimated to be worth US$ 14.21 billion in 2024 and is forecast to a readjusted size of US$ 22.74 billion by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.

Download Free Sample PDF Report (with full TOC, tables, and charts) To Explore Detailed Insights and Forecasts @ https://qyresearch.in/request-sample/medical-devices-consumables-liver-disease-diagnostics-global-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

The liver is an organ about the size of a football. It sits just under your rib cage on the right side of your abdomen. The liver is essential for digesting food and ridding your body of toxic substances. Liver disease can be inherited (genetic). Liver problems can also be caused by a variety of factors that damage the liver, such as viruses, alcohol use and obesity. Over time, conditions that damage the liver can lead to scarring (cirrhosis), which can lead to liver failure, a life-threatening condition. But early treatment may give the liver time to heal.

There are multiple causes of liver disease. While some are infective, some are genetic or autoimmune and some metabolic. This makes diagnosis difficult and often there are a battery of tests that need to be performed in order to correctly diagnose the underlying cause for the disease. Blood tests, biopsy and imaging tests are often used to check for liver disease.

Global key players of Liver Disease Diagnostics include Abbott, Roche and Thermo Fisher Scientific, etc. The top three players hold a share over 15%. North America is the largest market, has a share about 40%. In the market segment, imaging examinations (such as ultrasound, CT, MRI) dominate, accounting for about 60%, and are mainly used for screening and staging of diseases such as liver fibrosis and liver cancer. At the same time, in terms of downstream, hospitals and clinics are the largest downstream field, accounting for about 72% of the market share.

Competitive Landscape: -

Abbott
Roche
Thermo Fisher Scientific
Randox Laboratories
Boston Scientific
LabCorp
Fujifilm Corporation
Siemens Healthineers
BD
Cook Medical
GE Healthcare
Philips Healthcare
Canon Medical Systems
Qiagen

The competitive landscape is a must-have information for the market players to withstand the competition present in the global Liver Disease Diagnostics market. This further helps the market participants to develop effective strategies to optimize their market positions. Moreover, the competitive analysis helps them to determine potential advantages as well as barriers within the global Liver Disease Diagnostics market. This way, they can monitor how their competitors are implementing various strategies including pricing, marketing, and distribution.

Future development trend -

Early screening and early diagnosis technology breakthrough

Liquid biopsy (such as ctDNA, exosome detection) has great potential in early screening of liver cancer and can replace traditional invasive biopsy.

Multi-omics technology (genome, metabolomics) combined with AI models promotes personalized diagnosis and treatment.

Intelligent and digital integration

AI-assisted image analysis (such as liver cancer image segmentation, liver fibrosis staging) improves diagnostic efficiency.

Telemedicine and digital diagnosis and treatment platforms (such as liver disease full-process management APP) optimize patient follow-up processes.

Multidisciplinary collaboration and precision treatment

Combined medical and surgical treatment (such as the application of ERCP in complications of liver cirrhosis) and targeted drug development (such as HBV functional cure drugs) have become hot topics.

Regional market differentiation

North America is still the largest market (accounting for 40%), but Asia-Pacific (especially China) has the fastest growth rate, benefiting from policy support and the rise of local companies.

Regional Insights -

The report takes readers on a journey through four key regions: United States, Asia-Pacific, and EMEA. Key nations like the United States, Germany, the United Kingdom, China, Japan, South Korea, and more are thoroughly examined. The data is presented in a timeline from 2024 as the base year, with projections extending to 2031.

North America: United States, Canada, Mexico

Latin America: Brazil and other key markets

Asia Pacific: China, Japan, South Korea, India, ASEAN countries

Europe, Middle East & Africa (EMEA): Major European economies, GCC countries, and African nations

The report provides a region-wise breakdown of market share, consumption trends, and future prospects.

Detailed of Liver Disease Diagnostics Market Segmentation -

The report offers great insights into important segments of the global Liver Disease Diagnostics market while concentrating on their CAGR, market size, market share, and future growth potential. The global Liver Disease Diagnostics market is mainly segmented according to type of product, application, and region. Each segment in these categories is extensively researched to become familiar with their growth prospects and key trends. Segmental analysis is highly important to identify key growth pockets of a global market. The report provides specific information on the market growth and demand of different products and applications to help players to focus on profitable areas of the global Liver Disease Diagnostics market.

Segmentation By Type :-

Imaging Tests
Blood Tests
Biopsy

Segmentation By Application -

Hospitals and Clinics
Diagnostic Centers
Others

This segmentation helps identify high-growth opportunities and niche segments for investors and businesses.

Request for Pre-Order Enquiry On This Exclusive Report @ https://qyresearch.in/pre-order-inquiry/medical-devices-consumables-liver-disease-diagnostics-global-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Why This Report is a Must-Have -

ᗒ Historical Analysis (2020-2024) & Forecasts (2025-2031): Gain a clear understanding of market trends and future growth potential.

ᗒ Comprehensive Market Segmentation: Detailed breakdown by Type, Application, and Region to identify lucrative opportunities.

ᗒ Competitive Landscape: Insights into key players, their market share, and strategic developments like mergers, acquisitions, and expansion plans.

ᗒ Drivers & Restraints: Understand the factors shaping the market's growth and the challenges that could impact your strategy.

ᗒ Expert Opinions & Market Dynamics: Benefit from expert analysis to navigate market risks and capitalize on emerging trends.

Liver Disease Diagnostics Market Report Objectives -

(1) Analyzing the size of the global Liver Disease Diagnostics market on the basis of value and volume

(2) Accurately calculating the market shares, consumption, and other vital factors of different segments of the global Liver Disease Diagnostics market

(3) Exploring key dynamics of the global Liver Disease Diagnostics market

(4) Highlighting important trends of the global Liver Disease Diagnostics market in terms of production, revenue, and sales

(5) Deeply profiling top players of the global Liver Disease Diagnostics market and showing how they compete in the industry

(6) Studying manufacturing processes and costs, product pricing, and various trends related to them

(7) Showing the performance of different regions and countries in the global Liver Disease Diagnostics market

(8) Forecasting the market size and share of all segments, regions, and the global market.

Important Questions Answered included in the Report:-

(A) What is the market size and growth rate of the global and regional market by various segments?

(B) What is the market size and growth rate of the market for selective Countries?

(C) Which region or sub-segment is expected to drive the market in the forecast period?

(D) What factors are estimated to drive and restrain the market growth?

(E) What are the key technology and market trends shaping the market?

(F) what are the key opportunity in the market?

(G) Who are the leading manufacturers operating in the global Liver Disease Diagnostics market?

(H) Which key player accounted for the highest market share?

(I) What are the growth opportunities for the new entrants in the global Liver Disease Diagnostics market?

Table of Contents - Major Key Points:

1 Market Overview
1.1 Liver Disease Diagnostics Product Introduction
1.2 Global Liver Disease Diagnostics Market Size Forecast (2020-2031)
1.3 Liver Disease Diagnostics Market Trends & Drivers
1.3.1 Liver Disease Diagnostics Industry Trends
1.3.2 Liver Disease Diagnostics Market Drivers & Opportunity
1.3.3 Liver Disease Diagnostics Market Challenges
1.3.4 Liver Disease Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Liver Disease Diagnostics Players Revenue Ranking (2024)
2.2 Global Liver Disease Diagnostics Revenue by Company (2020-2025)
2.3 Key Companies Liver Disease Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Liver Disease Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Liver Disease Diagnostics
2.6 Liver Disease Diagnostics Market Competitive Analysis
2.6.1 Liver Disease Diagnostics Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Liver Disease Diagnostics Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Disease Diagnostics as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Purity
3.1 Introduction by Purity
3.1.1 Imaging Tests
3.1.2 Blood Tests
3.1.3 Biopsy
3.2 Global Liver Disease Diagnostics Sales Value by Purity
3.2.1 Global Liver Disease Diagnostics Sales Value by Purity (2020 VS 2024 VS 2031)
3.2.2 Global Liver Disease Diagnostics Sales Value, by Purity (2020-2031)
3.2.3 Global Liver Disease Diagnostics Sales Value, by Purity (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Diagnostic Centers
4.1.3 Others
4.2 Global Liver Disease Diagnostics Sales Value by Application
4.2.1 Global Liver Disease Diagnostics Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Liver Disease Diagnostics Sales Value, by Application (2020-2031)
4.2.3 Global Liver Disease Diagnostics Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Liver Disease Diagnostics Sales Value by Region
5.1.1 Global Liver Disease Diagnostics Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Liver Disease Diagnostics Sales Value by Region (2020-2025)
5.1.3 Global Liver Disease Diagnostics Sales Value by Region (2026-2031)
5.1.4 Global Liver Disease Diagnostics Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Liver Disease Diagnostics Sales Value, 2020-2031
5.2.2 North America Liver Disease Diagnostics Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Liver Disease Diagnostics Sales Value, 2020-2031
5.3.2 Europe Liver Disease Diagnostics Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Liver Disease Diagnostics Sales Value, 2020-2031
5.4.2 Asia Pacific Liver Disease Diagnostics Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Liver Disease Diagnostics Sales Value, 2020-2031
5.5.2 South America Liver Disease Diagnostics Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Liver Disease Diagnostics Sales Value, 2020-2031
5.6.2 Middle East & Africa Liver Disease Diagnostics Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Liver Disease Diagnostics Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Liver Disease Diagnostics Sales Value, 2020-2031
6.3 United States
6.3.1 United States Liver Disease Diagnostics Sales Value, 2020-2031
6.3.2 United States Liver Disease Diagnostics Sales Value by Purity (%), 2024 VS 2031
6.3.3 United States Liver Disease Diagnostics Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Liver Disease Diagnostics Sales Value, 2020-2031
6.4.2 Europe Liver Disease Diagnostics Sales Value by Purity (%), 2024 VS 2031
6.4.3 Europe Liver Disease Diagnostics Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Liver Disease Diagnostics Sales Value, 2020-2031
6.5.2 China Liver Disease Diagnostics Sales Value by Purity (%), 2024 VS 2031
6.5.3 China Liver Disease Diagnostics Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Liver Disease Diagnostics Sales Value, 2020-2031
6.6.2 Japan Liver Disease Diagnostics Sales Value by Purity (%), 2024 VS 2031
6.6.3 Japan Liver Disease Diagnostics Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Liver Disease Diagnostics Sales Value, 2020-2031
6.7.2 South Korea Liver Disease Diagnostics Sales Value by Purity (%), 2024 VS 2031
6.7.3 South Korea Liver Disease Diagnostics Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Liver Disease Diagnostics Sales Value, 2020-2031
6.8.2 Southeast Asia Liver Disease Diagnostics Sales Value by Purity (%), 2024 VS 2031
6.8.3 Southeast Asia Liver Disease Diagnostics Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Liver Disease Diagnostics Sales Value, 2020-2031
6.9.2 India Liver Disease Diagnostics Sales Value by Purity (%), 2024 VS 2031
6.9.3 India Liver Disease Diagnostics Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Profile
7.1.2 Abbott Main Business
7.1.3 Abbott Liver Disease Diagnostics Products, Services and Solutions
7.1.4 Abbott Liver Disease Diagnostics Revenue (US$ Million) & (2020-2025)
7.1.5 Abbott Recent Developments
7.2 Roche
7.2.1 Roche Profile
7.2.2 Roche Main Business
7.2.3 Roche Liver Disease Diagnostics Products, Services and Solutions
7.2.4 Roche Liver Disease Diagnostics Revenue (US$ Million) & (2020-2025)
7.2.5 Roche Recent Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Profile
7.3.2 Thermo Fisher Scientific Main Business
7.3.3 Thermo Fisher Scientific Liver Disease Diagnostics Products, Services and Solutions
7.3.4 Thermo Fisher Scientific Liver Disease Diagnostics Revenue (US$ Million) & (2020-2025)
7.3.5 Thermo Fisher Scientific Recent Developments
7.4 Randox Laboratories
7.4.1 Randox Laboratories Profile
7.4.2 Randox Laboratories Main Business
7.4.3 Randox Laboratories Liver Disease Diagnostics Products, Services and Solutions
7.4.4 Randox Laboratories Liver Disease Diagnostics Revenue (US$ Million) & (2020-2025)
7.4.5 Randox Laboratories Recent Developments
7.5 Boston Scientific
7.5.1 Boston Scientific Profile
7.5.2 Boston Scientific Main Business
7.5.3 Boston Scientific Liver Disease Diagnostics Products, Services and Solutions
7.5.4 Boston Scientific Liver Disease Diagnostics Revenue (US$ Million) & (2020-2025)
7.5.5 Boston Scientific Recent Developments
7.6 LabCorp
7.6.1 LabCorp Profile
7.6.2 LabCorp Main Business
7.6.3 LabCorp Liver Disease Diagnostics Products, Services and Solutions
7.6.4 LabCorp Liver Disease Diagnostics Revenue (US$ Million) & (2020-2025)
7.6.5 LabCorp Recent Developments
7.7 Fujifilm Corporation
7.7.1 Fujifilm Corporation Profile
7.7.2 Fujifilm Corporation Main Business
7.7.3 Fujifilm Corporation Liver Disease Diagnostics Products, Services and Solutions
7.7.4 Fujifilm Corporation Liver Disease Diagnostics Revenue (US$ Million) & (2020-2025)
7.7.5 Fujifilm Corporation Recent Developments
7.8 Siemens Healthineers
7.8.1 Siemens Healthineers Profile
7.8.2 Siemens Healthineers Main Business
7.8.3 Siemens Healthineers Liver Disease Diagnostics Products, Services and Solutions
7.8.4 Siemens Healthineers Liver Disease Diagnostics Revenue (US$ Million) & (2020-2025)
7.8.5 Siemens Healthineers Recent Developments
7.9 BD
7.9.1 BD Profile
7.9.2 BD Main Business
7.9.3 BD Liver Disease Diagnostics Products, Services and Solutions
7.9.4 BD Liver Disease Diagnostics Revenue (US$ Million) & (2020-2025)
7.9.5 BD Recent Developments
7.10 Cook Medical
7.10.1 Cook Medical Profile
7.10.2 Cook Medical Main Business
7.10.3 Cook Medical Liver Disease Diagnostics Products, Services and Solutions
7.10.4 Cook Medical Liver Disease Diagnostics Revenue (US$ Million) & (2020-2025)
7.10.5 Cook Medical Recent Developments
7.11 GE Healthcare
7.11.1 GE Healthcare Profile
7.11.2 GE Healthcare Main Business
7.11.3 GE Healthcare Liver Disease Diagnostics Products, Services and Solutions
7.11.4 GE Healthcare Liver Disease Diagnostics Revenue (US$ Million) & (2020-2025)
7.11.5 GE Healthcare Recent Developments
7.12 Philips Healthcare
7.12.1 Philips Healthcare Profile
7.12.2 Philips Healthcare Main Business
7.12.3 Philips Healthcare Liver Disease Diagnostics Products, Services and Solutions
7.12.4 Philips Healthcare Liver Disease Diagnostics Revenue (US$ Million) & (2020-2025)
7.12.5 Philips Healthcare Recent Developments
7.13 Canon Medical Systems
7.13.1 Canon Medical Systems Profile
7.13.2 Canon Medical Systems Main Business
7.13.3 Canon Medical Systems Liver Disease Diagnostics Products, Services and Solutions
7.13.4 Canon Medical Systems Liver Disease Diagnostics Revenue (US$ Million) & (2020-2025)
7.13.5 Canon Medical Systems Recent Developments
7.14 Qiagen
7.14.1 Qiagen Profile
7.14.2 Qiagen Main Business
7.14.3 Qiagen Liver Disease Diagnostics Products, Services and Solutions
7.14.4 Qiagen Liver Disease Diagnostics Revenue (US$ Million) & (2020-2025)
7.14.5 Qiagen Recent Developments
8 Industry Chain Analysis
8.1 Liver Disease Diagnostics Industrial Chain
8.2 Liver Disease Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Liver Disease Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Liver Disease Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

About Us:

QYResearch established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

Contact Us:

Arshad Shaha | Marketing Executive

QY Research, INC.
315 Work Avenue, Raheja Woods,
Survey No. 222/1, Plot No. 25, 6th Floor,
Kayani Nagar, Yervada, Pune 411006, Maharashtra
Tel: +91-8669986909
Emails - arshad@qyrindia.com
Web - https://www.qyresearch.in

This release was published on openPR.